secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allarity Therapeutics, Inc. (ALLR)
CIK:        0001860657
Form:       8-K
Filed at:   2023-03-24T23:59:59+00:00
Accession:  0001213900-23-022572
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 5.03, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allarity Therapeutics announces 1-for-35 reverse stock split effective March 24, 2023
--------------------------------------------------------------------------------

- Reverse split reduces outstanding shares from 34,294,582 to ~979,846; no change in authorized shares (750M).
- Split effective at 4:05 p.m. ET on March 24, 2023; trading begins post-split on Nasdaq March 27 under symbol ALLR.
- Purpose: to increase per-share price to meet Nasdaq minimum bid price requirement and support capital raising.
- Fractional shares rounded up to nearest whole share; proportional adjustments to options, warrants, and exercise prices.
- CUSIP changed to 016744203; board determined ratio after stockholder approval at special meeting on March 20, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860657/000121390023022572/0001213900-23-022572-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860657/000121390023022572/ea175667-8k_allarity.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-022572

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer